This trial is active not recruiting!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Glioblastoma
and you are
over 18
years old
1
This is an early phase trial to determine
the dosage and safety of the new treatment.
Show me locations

The purpose

A proof-of-concept clinical trial assessing the safety of the coordinated undermining of survival paths by 9 repurposed drugs combined with metronomic temozolomide (CUSP9v3 treatment protocol) for recurrent glioblastoma

Provided treatments

  • Drug: Temozolomide
  • Drug: Aprepitant
  • Drug: Minocycline
  • Drug: Disulfiram
  • Drug: Celecoxib
  • Drug: Sertraline
  • Drug: Captopril
  • Drug: Itraconazole
  • Drug: Ritonavir
  • Drug: Auranofin
Tris trial is registered with FDA with number: NCT02770378. The sponsor of the trial is University of Ulm and it is looking for 10 volunteers for the current phase.
Official trial title:
A Proof-of-concept Clinical Trial Assessing the Safety of the Coordinated Undermining of Survival Paths by 9 Repurposed Drugs Combined With Metronomic Temozolomide (CUSP9v3 Treatment Protocol) for Recurrent Glioblastoma